197 related articles for article (PubMed ID: 5058192)
1. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
DeWys WD
Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
[No Abstract] [Full Text] [Related]
2. Pulmonary metastases of the lewis lung tumor-cell kinetics and response to cyclophosphamide at different sizes.
Hill RP; Stanley JA
Cancer Treat Rep; 1977; 61(1):29-36. PubMed ID: 861961
[TBL] [Abstract][Full Text] [Related]
3. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
[TBL] [Abstract][Full Text] [Related]
5. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
Mattern J; Jaeger S; Wayss K; Volm M
Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapeutic responses of a primary tumor and its pulmonary metastases in murine tumor systems in relation to its proliferative properties].
Ohno K
Osaka Daigaku Shigaku Zasshi; 1984 Jun; 29(1):64-85. PubMed ID: 6590823
[No Abstract] [Full Text] [Related]
8. [Trial of chemotherapy on cancer dissemination and metastasis].
Franchi G; Donelli MG; Rosso R
Rev Eur Etud Clin Biol; 1970 Apr; 15(4):453-9. PubMed ID: 5421871
[No Abstract] [Full Text] [Related]
9. Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function.
Pavlidis NA; Schultz RM; Chirigos MA; Luetzeler J
Cancer Treat Rep; 1978 Nov; 62(11):1817-22. PubMed ID: 728899
[TBL] [Abstract][Full Text] [Related]
10. Rotational stress reduces the effectiveness of antitumor drugs in mice.
Giraldi T; Perissin L; Zorzet S; Rapozzi V
Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
[No Abstract] [Full Text] [Related]
11. Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors.
DeWys WD
Cancer Res; 1972 Feb; 32(2):374-9. PubMed ID: 4258017
[No Abstract] [Full Text] [Related]
12. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
Ho W; Furst A
Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
[No Abstract] [Full Text] [Related]
13. An experimental tumour model for the study of the effects of chemotherapy and immunotherapy in combination with surgery.
Winsey HS; Mathé G; Thompson R
Br J Surg; 1971 Apr; 58(4):303. PubMed ID: 5572349
[No Abstract] [Full Text] [Related]
14. Drug-induced inhibition of tumour cell dissemination.
Burrage K; Hellmann K; Salsbury AJ
Br J Pharmacol; 1970 May; 39(1):205P-206P. PubMed ID: 5420103
[No Abstract] [Full Text] [Related]
15. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
16. An experimental model for studying factors which influence metastasis of malignant tumors.
Karrer K; Humphreys SR; Goldin A
Int J Cancer; 1967 May; 2(3):213-23. PubMed ID: 6041988
[No Abstract] [Full Text] [Related]
17. Stem-cell survival and tumor control in the Lewis lung carcinoma.
Steel GG; Adams K
Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
[TBL] [Abstract][Full Text] [Related]
18. Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.
Sacchi A; Calabresi F; Greco C; Zupi G
Invasion Metastasis; 1981; 1(4):227-38. PubMed ID: 6203864
[TBL] [Abstract][Full Text] [Related]
19. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
20. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
